Moderna's Integration of AI with OpenAI's ChatGPT
Moderna's Integration of AI with OpenAI's ChatGPT
Moderna has leveraged OpenAI's ChatGPT Enterprise to revolutionize its operations, integrating AI into various functions to enhance productivity and innovation. Since early 2023, this collaboration has empowered Moderna's employees by facilitating novel use cases across the company.
Aiming for widespread AI adoption, Moderna implemented a comprehensive change management program, including individual and collective training initiatives. This effort led to the successful launch of an internal AI chatbot, mChat, widely adopted by employees, paving the way for the broader implementation of ChatGPT Enterprise.
With the adoption of ChatGPT Enterprise, Moderna quickly saw significant engagement, with hundreds of unique GPTs created to streamline tasks across teams. This integration supports clinical trial development, legal compliance, and communication efforts, ensuring efficiency and accuracy.
Moderna's strategic use of AI allows the company to maintain a lean workforce while achieving ambitious goals, ultimately translating technological advancements into better patient outcomes. This collaboration exemplifies how AI can drive transformation and innovation in the pharmaceutical industry.
